Epinephrine Autoinjector Market - Global Analysis and Forecast Report 2019

Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the body. Adrenaline prepares the body to fight against anaphylactic shock that occurs due to allergic reactions, cardiac arrest, asthma, and superficial bleeding. Chemically synthesized epinephrine is usually administered to patients suffering from the above symptoms because it stimulates the heartbeat, increases blood pressure, relaxes involuntary muscles, and constricts small blood vessels. Epinephrine is also used with local anesthetic agents such as bupivacaine and lidocaine to enhance the effect of anesthesia. It is available in injection form as well as aerosol form for inhalation.

Epinephrine auto-injector is an emergency injection (“shot”) of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.

The analysts forecast the Global Epinephrine Auto-injector Market to grow at a CAGR of 13.12 percent over the period 2014-2019.

This report covers the present scenario and the growth prospects of the Global Epinephrine Auto-injector market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various epinephrine auto-injectors that are available in the market.

The report, Global Epinephrine Auto-injector Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase a copy of the report at .

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • ALK Abello
  • Amedra Pharmaceuticals
  • Lincoln Medical
  • Mylan
  • Sanofi

Other Prominent Vendors

  • Adamis Pharmaceuticals
  • Antares Pharma
  • Hospira
  • Intelliject
  • Teva Pharmaceutical Industries

Market Driver

  • Increased Prevalence of Allergies

Market Challenge

  • Adverse Side Effects

Market Trend

  • Development of CFC-free Epinephrine Auto-injectors

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For more Information on the report, inquire at .

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.